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Supplemental Materials and Methods
Bacterial strains, plasmids, and reagents. Bacterial strains and plasmids used and constructed in this study are listed in Table S1 . Chemicals, enzymes, and other molecular biological reagents were purchased from standard commercial sources and used according to the manufacturers' recommendations. Cloning, Overexpression and Purification of CrmK. The crmK gene was PCR amplified from the genomic DNA of A. cyanogriseus WH1-2216-6 using primers
CrmK-EF and CrmK-ER (Table S2) . PCR products were digested with EcoRI/XhoI and subsequently inserted into pET28a linearized with EcoRI/XhoI, to yield the plasmid pCSG2218 after sequence confirmation. The plasmid pCSG2218 were introduced to E. coli BL21(DE3) to produce the N-(His)6-tagged CrmK proteins. An overnight culture of transformed E. coli BL21(DE3)/pCSG2218 was used to inoculate 1 L TB medium and was grown at 37°C until the absorbance at 600 nm reached 0.6. Protein expression was induced with 100 µM isopropyl 1-thio-β-Dgalactopyranoside (IPTG) followed by incubation at 18°C for 20 h. Cells were harvested and resuspended in lysis buffer (50 mM Tris-HCl, 200 mM NaCl, 5%
glycerol, and 1 mM DTT, pH 8.0). An additional 5 mM imidazole was added to the lysis buffer and the overexpressed CrmK was purified by standard affinity chromatography using Ni 2+ -NTA affinity resin (Qiagen The structure solution for the CrmK-FAD complex was obtained by molecular replacement through MolRep 3 using the structure of TamL 4 (PDB code 2Y08) as the search model. Several cycles of refinement using REFMAC5 5 followed by
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model rebuilding with Coot 6 were carried out. For the substrate-bound CrmK, guided by the Fourier difference map, the substrate molecule was placed in the model after the rebuilding of the protein part was finished. Except the first 2-3 residues at the N-terminal, all the residues in the sequence are clearly visible in the electron density maps. Both models have good stereochemistry as analyzed with PROCHECK. 7 Data collection and refinement statistics for both structures were shown in Table 1 . 
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F123AF 5' -ACGTTCCCCGGCGGTGCCTGCATGGGGGTCG -3' crmK F123A mutagenesis F123AR 5' -GCACCGCCGGGGAACGTCACCCCGTAGTT -3' C124AF 5' -CG TTCCCCGGCGGTTTCGCCATGGGGGTCGGG -3' crmK C124A mutagenesis C124AR 5' -GCGAAACCGCCGGGGAACGTCACCCCGTAGTT -3' Y138FF 5' -AC ATCTCCGGTGGGGGCTTCGGGCCGCTCTCG -3' crmK Y138F mutagenesis Y138FR 5' -AA GCCCCCACCGGAGAT GTGGCCGCCCGCCCC -3' I328AF 5' -CGACCAGCCAGCTGTTGGCGGCCCCCGACGTGGGG -3' crmK I328A mutagenesis I328AR 5' -GCCGCCAACAGCTGGCTGGTCGCCAACCACGGCAAC -3' R340AF 5' -CGGGTGCGATCGGGGTGCGGGCGAAGGTCAAGTCC -3' crmK R340A mutagenesis R340AR 5' -GCCCGCACCCCGATCGCACCCGGCCCCACGTCGG -3' E376AF 5' -ACTGCCCCAGCGCCGCGATGGCGTACATCGCCTAC -3' crmK E376A mutagenesis E376AR 5' -GCCATCGCGGCGCTGGGGCAGTGGTAGTCGGCCC -3' I378AF 5' -GCGCCGCGATGGAGTACGCCGCCTACGGCGGG -3' crmK I378A mutagenesis I378AR 5' -GCGTACTCCATCGCGGCGCTGGGGCAGTGGTA -3' F403AF 5' -GCGGGGCGTCGTTGAAGACCGCCTACATGGTGGC -3'G crmK F403A mutagenesis F403AR 5' -GCGGTCTTCAACGACGCCCCGC GGGGAACCGCCGT -3' F403EF 5' -GCGGGGCGTCGTTGAAGACCGAGTACATGGTGGCG -3' crmK F403E mutagenesis F403ER 5' -CTCGGTCTTCAACGACGCCCCGCGGGGAACCGCCGT -3' M405AF 5' -CGTCGTTGAAGACCTTCTACGCGGTGGCGTGGACC -3' crmK M405A mutagenesis M405AR 5' -GCGTAGAAGGTCTTCAACGACGCCCCGCGGGGAA -3' Y446FF 5' -AGGTCAACACGGGCGCCTACATCAACTACCCC -3' crmK Y446F mutagenesis Y446FR 5' -AAGGCGCCCGTGTTGACCTCGTCGGGGGTGGG -3' Y449FF 5' -ACGGGCGCCTACATCAACTTCCCCGACATCGAC -3' crmK Y449F mutagenesis Y449FR 5' -AAGTTGATGTAGGCGCCCGTGTTGACCTCGTC -3'
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Fig. S1 Alignment of CrmK with bi-covalent flavinproteins from diverse pathways. GAYVNYPDVDLADEEWNTSGVPWSELYYKDAYPRLQAVKARWDPRNVFRHALSVRVPPA-500 TrdL GAYVNYPDVDLADEEWNTSGVPWSELYYKDAYPRLQAVKARWDPRNVFRHALSVRVPPA-500 Orf22 GAYVNYPDTDLADPRWNTSGVPWSTLYYKDNYPRLRRVKASWDPKGVFRHALSVEPPASE 508 *:::** * **.* ***** * :** :***: *: :**: *:*.:*:. The dual active site (Tyr450/Tyr144, Tyr378/Ser376) was proposed to be responsible to catalyze two different dehydrogenation reactions in AknOx catalysis.
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Fig. S8 Superposition of active site residues in AknOx and CrmK.
The carbon atoms of catalytic residues in AknOx (Y450/Y144 and Y378) 18 and CrmK (Y449/Y138 and E376) are colored in green and yellow, respectively. The carbon atoms of ligands are shown in cyan and green, respectively. Notably, upon superposition, the carboxylate group of E376 of CrmK is very close (~1.3 Å )
to the hydroxyl group of Y378 in AknOx. 
